Skip to content
Search

Latest Stories

What sustainability measures pharmacies can take to help combat climate change?

What sustainability measures pharmacies can take to help combat climate change?

Pharmacist Clinical Writer, Sandra Hicks shares how pharmacists, patients and pharmaceutical companies can help minimize their impact on the environment

Thanks to increasing environmental awareness among people worldwide, there’s a growing commitment to sustainable practices across industries. The healthcare sector, including pharmacies, is no exception.


Recognising the fact that ‘climate crisis is a health crisis’, 124 countries signed a new Declaration on Climate and Health at the first-ever Health Day at the United Nations climate change conference, COP28 Dubai, which was held on 3 December 2023.

The declaration acknowledged the need to prepare healthcare systems to cope with climate change and accelerate actions to protect communities.

Welcoming the declaration, Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO) emphasized the need to build “climate-resilient and low-carbon” health systems to protect the health of both the planet and people.

Pharmacies play a crucial role in providing essential medications and healthcare services to the community, but their operations can have environmental implications.

It is estimated that medicines account for about 25 per cent of carbon emissions within the National Health Service (NHS).

So, how pharmacies can contribute to a healthier planet while continuing to fulfill their vital role in healthcare delivery?

Sustainability measures pharmacies can take   

In the latest PDA member voice article, PDA member and Pharmacist Clinical Writer, Sandra Hicks shared several ways that pharmacists, patients and pharmaceutical companies can help to combat climate change.

She said: “Advances such as the Declaration are hard-won, but as current commitments on reducing emissions aren’t enough to prevent catastrophic outcomes, this is no time for complacency.”

According to her, a pharmacy can help minimize its impact on the environment by reducing overprescribing and medicines optimisation to avoid waste; advising patients on improving their lifestyle by exercising and eating healthy, and considering plant-based diets; and helping patients to manage their medicines and follow-up on their own and review their needs regularly.

She also suggested that pharmacy initiatives should be linked to the Centre for Sustainable Healthcare (CSH) four principles of sustainability, which are:

  • Prevention
  • Patient empowerment
  • Lean service delivery
  • Low carbon alternatives

She asked patients to return unused medicines to their local pharmacy so that the products can disposed of appropriately, rather than “putting any in household waste or tipping liquids down the sink or flushing them down the toilet.”

Patients are also advised to check their dispensed medicines before leaving the pharmacy to avoid waste from “unwanted/incorrect supplies.”

Hicks said that pharmaceutical companies can help combat climate change by introducing more recycling schemes and extending Chiesi’s inhaler recycling scheme or Novo Nordisk’s Pencycle scheme, and adopting make biodegradable packaging.

“Overall, small actions collectively have a big impact,” she added.

Highlighting the impact of climate change on human health, she cited The Lancet Countdown Report, which warned that life-threatening temperatures are becoming increasingly common, transmission of deadly infectious diseases is rising, and weather extremities are causing food and shelter insecurity for millions of people.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less